NCT00161083View on ClinicalTrials.gov

UDCA for Symptomatic Gallstone Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

November 30, 2004

Conditions
Cholecystolithiasis
Interventions
DRUG

ursodeoxycholic acid

Trial Locations (1)

3508 GA

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

Dr. Falk Pharma GmbH
All Listed Sponsors
collaborator

Dr. Falk Pharma GmbH

INDUSTRY

collaborator

Dutch Digestive Diseases Foundation

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Agis Zorgverzekeringen

OTHER

lead

UMC Utrecht

OTHER